Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

Get ready for an onslaught of ads full of celebrities, cute animals and snack brands during breaks in the action at the Super ...

Not long after reporting phase 2 data for one of its obesity candidates that appeared to put it on par with Eli Lilly’s Zepbound, Kailera Therapeutics is preparing for an eventual market launch ...

Amazon released a new AI product in its demand-side platform focused on connected TV advertisers, helping them target brand ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Amazon Ads is rolling out Brand+, a new offering for marketers combining "trillions of signals" from shopping, browsing and ...

While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss drugs of its own: Mounjaro and Zepbound. Mounjaro and Zepbound are by ...

Cumulus Media/Westwood One Chief Insights Officer Pierre Bouvard is sharing more specific tips to help brands beat boring ads ...

The Phoenix Suns three-time All-Star Devin Booker premiered his new Nike "Book 1" signature shoe commercial on Instagram ...